Additional pathways significantly associated with TRIP13 expression in glioma were “G2/M DNA damage checkpoint” (p = 2.34 × 10−9), “ATM signaling” (p = 2.95 × 10−7) and “Mismatch repair in eukaryotes” (p = 4.79 × 10−5), the top canonical pathways are shown in Figure 5C and Table S5. The gene discussed is TRIP13; the disease is central nervous system cancer.